Harrisburg, NC -- (SBWire) -- 01/31/2019 --Global Companion Diagnostics Market report elaborates the complete details covering product definition, product type, and application. The report covers useful details which are categorized based on Companion Diagnostics production region, major players, and product type which will provide a simplified view of the Companion Diagnostics industry. The Companion Diagnostics market report presents the competitive scenario of the major market players based on the sales revenue, customer demands, company profile, the business tactics used in Companion Diagnostics market which will help the emerging market segments in making vital business decisions.
The global companion diagnostics market has been estimated at USD 5.8 billion in 2017. The market is expected to register a CAGR of 22.7% during the forecast period (2018-2023).
Global Companion Diagnostics Market by Top Manufacturers (2019-2023): ABBOTT LABORATORIES, DAKO (AGILENT TECHNOLOGIES), ROCHE HOLDINGS, QIAGEN NV, SEIMENS HELTHINEERS, TAKEDA PHARMACEUTICALS, MYRIAD GENETICS, THERMO FISHER SCIENTIFIC, TACOGEN, AND ILLUMINA INC., among others
Inquire for sample copy at: https://www.marketinsightsreports.com/reports/01241065389/global-companion-diagnostics-market-segmented-by-treatment-type-and-geography-growth-trends-and-forecasts-2018-2023/inquiry?source=releasewire&Mode=28
Essential points covered in Companion Diagnostics Market 2019 Research are:-
- Current and future Companion Diagnostics market outlook in the developed and emerging markets
- Analyzing various perspectives of the market with the help of Porters five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identifying the latest developments, market shares, and strategies employed by the major market players
- 3-month analyst support, along with the Market Estimate sheet (in Excel).
This independent 108 pages report guarantees you will remain better informed than your competition. With figures examining the Companion Diagnostics market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leader's market revenue forecasts as well as analysis to 2023.
Regional Analysis For Companion Diagnostics Market:
For comprehensive understanding of market dynamics, the global Companion Diagnostics market is analyzed across key geographies namely: North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
SPECIAL OFFER :- Avail a Flat 15% Discount on this report:
https://www.marketinsightsreports.com/reports/01241065389/global-companion-diagnostics-market-segmented-by-treatment-type-and-geography-growth-trends-and-forecasts-2018-2023/discount?source=releasewire&Mode=28
North America Dominates the Market:
North America accounted for the largest market share, accounting for approximately 35% of the global market in 2017. The efficacy of several drugs range between 30-75%, and there have been rising cases of side effects related to therapeutics, such as Vioxx and Avandia, which has prompted people to look for alternatives and raised their awareness regarding the benefits of personalized medicine. These factors are driving the North American market. Apart from this, the Asia-Pacific region was estimated to register the fastest CAGR over the forecast period.
Key Developments in the Market:
January 2018: Myriad Genetics received FDA approval for BRACAnalysis CDx as Companion Diagnostic for Lynparza (olaparib).
January 2018: A new companion diagnostics agreement between Biocartis Group and Amgen was signed for the development of Idylla CDx biomarker tests, used in the treatment of certain solid tumors.
December 2017: HTG Molecular Diagnostics signed master collaboration with Merck KGaA, complementing the companion diagnostics agreement for biomarker research program.
Browse full report at: https://www.marketinsightsreports.com/reports/01241065389/global-companion-diagnostics-market-segmented-by-treatment-type-and-geography-growth-trends-and-forecasts-2018-2023?source=releasewire&Mode=28
Reasons to Purchase This Report
- Current and future market outlook for companion diagnostics in developed and emerging markets
- Analyzing various perspectives on the market with the help of Porters five forces analysis
- The treatment type that is expected to dominate the market
- The regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, market shares, and strategies employed by the major market players
- Three-month analyst support, along with the Market Estimate sheet in Excel.
About MarketInsightsReports
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact Us:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com
Companion Diagnostics Market Challenges, Current Trends and Future Growth Forecast to 2023